Continuing vasodilator infusion therapy; utilization of a blend of 1-hydrazinophthalazine (apresoline) and cryptenamine (unitensen) in toxemia of pregnancy.
D005260:Female; D006830:Hydralazine; D011225:Pre-Eclampsia / Q000628:therapy*; D011247:Pregnancy; D011526:Protoveratrines; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents; D014704:Veratrum Alkaloids / Q000627:therapeutic use*
D011526:Protoveratrines; D013565:Sympatholytics; D014665:Vasodilator Agents; D014704:Veratrum Alkaloids; D006830:Hydralazine
PREGNANCY TOXEMIAS/therapy; SYMPATHOLYTICS/therapeutic use; VERATRUM ALKALOIDS/therapeutic use